Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

Clinical trial NCT06424470 · COMPLETED

Trial details

NCT number: NCT06424470
Sponsor: Keymed Biosciences Co.Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2024-06-25
Primary completion: 2026-02-11
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.